You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

~ Buy the JATENZO (testosterone undecanoate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR JATENZO


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for jatenzo

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03973840 ↗ Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes Completed Celerion; Syneos Health; ARUP Laboratories Phase 1 2018-07-15 To describe the rate of post-collection TU to testosterone conversion, as manifested by increases in testosterone concentration, in Plain tubes held at room temperature and sodium fluoride (NaF)-ethylenediaminetetraacetic acid (EDTA) tubes held at room temperature or on ice prior to centrifugation
NCT03973840 ↗ Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes Completed Clarus Therapeutics, Inc. Phase 1 2018-07-15 To describe the rate of post-collection TU to testosterone conversion, as manifested by increases in testosterone concentration, in Plain tubes held at room temperature and sodium fluoride (NaF)-ethylenediaminetetraacetic acid (EDTA) tubes held at room temperature or on ice prior to centrifugation
NCT04983940 ↗ Patient Satisfaction After Switching to Oral Testosterone Undecanoate Recruiting Clarus Therapeutics Phase 4 2021-06-18 The purpose of this research study is to evaluate patient satisfaction with an oral testosterone agent, Jatenzo, compared to other forms of testosterone therapy.
NCT04983940 ↗ Patient Satisfaction After Switching to Oral Testosterone Undecanoate Recruiting University of Miami Phase 4 2021-06-18 The purpose of this research study is to evaluate patient satisfaction with an oral testosterone agent, Jatenzo, compared to other forms of testosterone therapy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for jatenzo

Condition Name

Condition Name for jatenzo
Intervention Trials
Hypogonadism, Male 2
Kidney Disease, Chronic 1
Metastatic Castration-resistant Prostate Cancer 1
Prostate Cancer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for jatenzo
Intervention Trials
Eunuchism 2
Hypogonadism 2
Renal Insufficiency, Chronic 1
Kidney Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for jatenzo

Trials by Country

Trials by Country for jatenzo
Location Trials
United States 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for jatenzo
Location Trials
Missouri 1
Maryland 1
Florida 1
Illinois 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for jatenzo

Clinical Trial Phase

Clinical Trial Phase for jatenzo
Clinical Trial Phase Trials
Phase 4 1
Phase 2 2
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for jatenzo
Clinical Trial Phase Trials
Recruiting 2
Not yet recruiting 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for jatenzo

Sponsor Name

Sponsor Name for jatenzo
Sponsor Trials
Clarus Therapeutics 3
Celerion; Syneos Health; ARUP Laboratories 1
Clarus Therapeutics, Inc. 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for jatenzo
Sponsor Trials
Other 7
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.